Henry Ford Hospital Medical Journal
Volume 6 | Number 3

Article 4

9-1958

A Previously Unreported Effect Of The Prolonged
Administration Of Desiccated Thyroid
Thomas Baumgartner
J. Martin Miller

Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal
Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health
Commons
Recommended Citation
Baumgartner, Thomas and Miller, J. Martin (1958) "A Previously Unreported Effect Of The Prolonged Administration Of Desiccated
Thyroid," Henry Ford Hospital Medical Bulletin : Vol. 6 : No. 3 , 256-259.
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol6/iss3/4

This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry
Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. For more information, please contact
acabrer4@hfhs.org.

A PREVIOUSLY UNREPORTED EFFECT OF THE PROLONGED
ADMINISTRATION OF DESICCATED THYROID
THOMAS BAUMGARTNER, M.D.* AND I . M A R T I N M I L L E R ,

M.D.*

The effect of prolonged thyroid administration in the euthyroid patient has
received a minor degree of attention in the medical literature. Avaflable reports have
emphasized the apparent complete recovery of the thyroid gland after abrupt or gradual
discontinuance of exogenous thyroid medication administered over varying periods of
time.'-" Recovery usually occurred within three months after cessation of thyroid
feeding, based on both clinical and laboratory evidence. Since the administration of
exogenous thyroid hormone suppresses thyrotropic hormone of the anterior pituitary
and leads to involution of the thyroid gland, the question may be raised that if a total
replacement dose of thyroid were taken over a long period of time, might not irreversible atrophy of the gland eventually take place. We have recently had occasion to
observe three patients who had been on thyroid hormone in doses of 120 to 180
mifligrams for 15 to 25 years and whose thyroids were refractory to the administration
of exogenous TSH at the time they were seen in the clinic. A l l had been placed on
thyroid originally for reasons that seemed unrelated to thyroid hypofunction, and
they seemed in no way to differ from the large group of patients whose thyroid therapy
is initiated for reasons that are best described charitably as "empirical". One of these
cases had been studied in sufficient detail so that certain speculative observations can
be made.
CASE REPORT: M . A., a 32-year-old white housewife, was first seen at Henry Ford
Hospital in 1942 with the chief complaint of cough. The only symptom possibly
relating to disorder of thyroid function was that of fatigue. Physical examination was
entirely normal. The blood pressure was 110/70, pulse rate 80. The skin was warm
and smooth. The reflexes were recorded as normal. Two years later, she was seen
by her family physician for fatigue and nervousness over a family situation. A B.M.R.
was performed which, to the patient's recollection, was —30. She was placed on
desiccated thyroid up to 180 mifligrams dafly with no appreciable change in her
symptoms. She was again seen at Henry Ford Hospital in the Gynecology Division
in 1951, at which time she was taking 90 milligrams of USP thyroid. Her B.M.R. was
—17 and a year later, having increased the thyroid dose to 120 mifligrams, it was —6.
In 1958 her B.M.R. was —14 whfle she continued on 120 mflligrams of thyroid. She
was subsequently seen in the Endocrine Clinic where a review of her history revealed
that in the previous year she had stopped thyroid for two weeks with no obvious ill
effect. The thyroid medication was terminated and six weeks later she noted some
cold intolerance, increasing fatigue and had gained ten pounds in weight. The only
objective change on physical examination was some slowing of the recovery phase of
the deep tendon reflexes. No further medication was given for the next six weeks
and on her return she had developed a full-blown picture of myxedema with infraorbital
swelling, dryness and thickening of the skin, slowness of speech, constipation, and
'•Division of Endocrinology.
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marked slowing of the recovery phase of the deep tendon reflexes. Her B.M.R. was
—33. The protein-bound iodine was 1.2 micrograms per cent. The radioactive iodine
uptake in three hours was four per cent. In order to ascertain whether the thyroid
was capable of being stimulated, five units of TSH were administered daily for three
days, at the end of which time the three-hour 1-131 uptake was stifl four per cent.
Thyroid was again prescribed. Her most recent B.M.R. was —11 after two months
maintenance therapy of 180 milligrams dafly.
DISCUSSION: Previous reports on the effects of exogenous thyroid ingestion in
euthyroid subjects have emphasized the complete recovery of the thyroid gland after
the cessation of treatment. This has been observed in patients receiving physiologic
or greater amounts for prolonged periods of time. These reports have stressed the
absence of clinical signs of myxedema, even in those patients whose indices of thyroid
function did not return to normal or pre-treatment levels for considerable periods of
time. The patient of this report presented classical features of myxedema three months
after stopping thyroid therapy. The B.M.R. of —33, the P.B.I, of 1.2 micrograms,
and the three-hour 1-131 uptake of four per cent, all support this diagnosis. The
failure of the thyroid gland to respond to three days of TSH administration confirms
the presence of primary thyroid failure. Stanley and Astwood^ have demonstrated
that human subjects do not accumulate an appreciable amount of thyroidal radioactive
iodine while under the influence of exogenous thyroid hormone, but such glands can
be stimulated to normal activity within eight hours following a single small dose of
thyrotropic hormone.
We are unable to state with certainty that this patient (or the other two patients
referred to in the introduction) did not have hypothyroidism at the time thyroid was
first prescribed. Neither can we prove that if they were indeed euthyroid initiafly.
the reason for subsequent hypothyroidism was causally related to the prolonged dormant
state of the gland. In our experience, the majority of patients previously given thyroid
because of low basal metabolic rates have no true thyroid deficiency. They have not
been found hypothyroid by any other parameters of thyroid function, and the responses
of the B.M.R. to desiccated thyroid have been highly variable. We consider the patient
of the present report to fall into this classification for the following reasons: 1) two
years before thyroid therapy, she had no symptoms or findings suggestive of hypothyroidism, and she developed none prior to therapy; 2) the administration of 180
milligrams of desiccated thyroid produced no improvement in the symptoms of afleged
thyroid dysfunction; 3) subsequent cessation of thyroid therapy led to frank clinical
myxedema, easily recognized by the patient as an entirely new set of symptoms.
These cases were originally studied to see if the long-term administration of thyroid
hormone might permanently suppress pituitary thyrotropin with resulting myxedema.
Whether or not this happened or spontaneous selective (TSH) failure of anterior
pituitary function occurred, we cannot state. I f either one, the thyroid gland in
addition became unresponsive to exogenous TSH. Other authors have mentioned the
importance of withholding thyroid for periods up to six months before assessing the
thyroid function after prolonged use of the hormone. We considered this unnecessary
because the gland had been found unresponsive to thyroid stimulating hormone.
It is our interpretation that this case represents induced myxedema from prolonged
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thyroid feeding in an initially euthyroid individual. This type of therapy will cause
suppression of endogenous TSH, leading to involution of the thyroid gland. It may
produce eventual irreversible atrophy with inability to respond to thyrotropic hormone,
comparable to the state of primary myxedema. This observation is not consistent with
previous reports in the literature. In 1941 Farquharson and Squires were the first
to call attention to the inhibflion of thyroid secretion following continued ingestion
of thyroid substances.' They gave thyroid to several euthyroid patients with obesity,
neuroses, or minor chronic disorders. The period of therapy varied from several
months to more than two years. A l l patients were given at least 120 milligrams of
thyroid daily, and for some the dose was 300 milligrams. The treatment was stopped
abruptly. The B.M.R. fell rapidly to below pre-treatment levels, and some patients
complained of mfld fatigue, weakness, and cold intolerance. Over a period of several
weeks, however, the B.M.R. gradually returned toward pre-treatment levels. By three
months, all had stabilized at the initial level and symptoms previously mentioned had
disappeared.
Johnston et al. in 1951 reported further observations with similar clinical condflions.^ Measurements of the B.M.R., protein-bound iodine and 1-131 uptake were
made at intervals before, during and after treatment with exogenous thyroid. The
dosage ranged from 120 to 600 mifligrams of thyroid daily. The period of observation
extended from one to three years. Thyroid ingestion was stopped abruptly. The B.M.R.
and P.B.I, fell rapidly below pre-treatment levels for one to three weeks, followed
by gradual rise to normal levels in two to three months. In the few patients having
1-131 studies, the initially suppressed uptakes returned to normal range within four
weeks after termination of thyroid feeding. Subjective symptoms of hypothyroidism
occurred in some patients, but all symptoms cleared in a short period of time. No
mention was made of clinical evidence to suggest myxedema.
In 1951, Greer reported the effect of exogenous thyroid administration on the
production of endogenous thyroid hormone by euthyroid subjects.' He used the 24-hour
1-131 uptake to assess thyroid function. Physiologic amounts of thyroid were given,
usuafly 120 to 180 mifligrams daily, for short periods of time. Four of the patients
had been taking 180 milligrams daily for several years. Twenty-four hour 1-131
uptakes were determined previous to, during and subsequent to ingestion of desiccated
thyroid. He found that marked suppression of 1-131 uptake could be produced in
one week with dafly administration of 60 to 180 milligrams of desiccated thyroid in
93 per cent of his 47 patients. One patient required 540 milligrams for several weeks
to reduce the 1-131 uptake to hypothyroid levels. Abrupt withdrawal of the hormone
resulted in a gradual return of the 24-hour 1-131 uptake to pre-treatment levels within
two weeks. A n occasional patient required a longer period to revert to the pretreatment range. In the four patients on 180 milligrams or more for several years,
1-131 uptakes returned to euthyroid range as promptly as those on short-term therapy.
No patient developed symptoms or signs of myxedema after stopping treatment. Greer
concluded that no permanent injury to the thyroid gland resulted from prolonged
exogenous thyroid ingestion in euthyroid subjects.
In 1954, Bartels and Higgins reported four cases in which prolonged thyroid
administration was stopped abruptly.^ AU subjects were considered euthyroid when
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therapy was instituted, as judged from the patient's history. One patient had taken
240 mifligrams of desiccated thyroid daily for eight months. Cessation of treatment
caused symptoms suggestive of hypothyroidism, but no clinical evidence supported
this. After five months she was euthyroid clinically, and the B.M.R. and serum
cholesterol were in the normal range. A second patient had been on 60 mg. of
thyroid plus Lugol's solution for 18 months. When these were stopped some symptoms
of hypothyroidism resulted but again no cflnical evidence supported fl. Within four
months these symptoms had disappeared and she was considered euthyroid.
SUMMARY: A case is presented of primary myxedema occurring after cessation of
prolonged thyroid therapy in what is presumed to have been an initially euthyroid
individual. I t is felt that long continued use of exogenous thyroid led to permanent
atrophy of the thyroid gland. Since the possibility exists that continued use of desiccated
thyroid can lead to irreversible damage to this gland, it is suggested that its prolonged
use be restricted to those cases in which clinical and laboratory findings indicate a
real need for replacement therapy.
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